MENU
VRTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Vertex Pharmaceuticals (VRTX) Ownership - Who owns Vertex Pharmaceuticals?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
50 Northern Avenue
Phone
+1 617 341-6100
Employees
5400
Web
https://www.vrtx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
120.84B
P/E Ratio
32.76
Total Cash
6.52B
Projected Growth
1.23
Total Debt
1.7B
Revenue
10.63B
Risk (Beta)
0.41
Dividend Yield
N/A
Total Cash/Share
25.33
Total Debt/Equity
43.97
Revenue/Share
41.06 USD as % of share price
Fundamentals
VRTX
Capitalization
121B
P/E Ratio
32.76
Risk (Beta)
0.41
Dividend Yield
N/A
Total Cash
6.52B
Total Cash/Share
25.33
Total Debt
1.7B
Total Debt/Equity
43.97
Projected Growth (PEG Ratio)
1.23
Revenue/Share (as % of the share price)
41.06%
Revenue
10.6B
ROE
N/A
Book Value
15.6B
P/B Ratio
7.73
Cash Flow
N/A
Earnings
-1.85
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2.6M
Current Ratio
2.47
Current Revenue Per Employee
513314.80
Dividends Per Share - Security
N/A
EBITDA
518M
Float
N/A
Float - Current
N/A
Gross Income Margin
85.84
Revenue To Assets
-2.18
Shares Held By Institutions
451B
Shares Outstanding - Current
258M
Total Liabilities
6.61B
Total Volume MTD
N/A
Value
-1
Gain YTD
15.324
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company that discovers and develops novel, small molecule pharmaceuticals
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
50 Northern Avenue
Phone
+1 617 341-6100
Employees
5400
Web
https://www.vrtx.com